Cargando…
CD38: T Cell Immuno-Metabolic Modulator
Activation and subsequent differentiation of T cells following antigenic stimulation are triggered by highly coordinated signaling events that lead to instilling cells with a discrete metabolic and transcriptional feature. Compelling studies indicate that intracellular nicotinamide adenine dinucleot...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408359/ https://www.ncbi.nlm.nih.gov/pubmed/32709019 http://dx.doi.org/10.3390/cells9071716 |
_version_ | 1783567814383108096 |
---|---|
author | Kar, Anwesha Mehrotra, Shikhar Chatterjee, Shilpak |
author_facet | Kar, Anwesha Mehrotra, Shikhar Chatterjee, Shilpak |
author_sort | Kar, Anwesha |
collection | PubMed |
description | Activation and subsequent differentiation of T cells following antigenic stimulation are triggered by highly coordinated signaling events that lead to instilling cells with a discrete metabolic and transcriptional feature. Compelling studies indicate that intracellular nicotinamide adenine dinucleotide (NAD(+)) levels have profound influence on diverse signaling and metabolic pathways of T cells, and hence dictate their functional fate. CD38, a major mammalian NAD(+) glycohydrolase (NADase), expresses on T cells following activation and appears to be an essential modulator of intracellular NAD(+) levels. The enzymatic activity of CD38 in the process of generating the second messenger cADPR utilizes intracellular NAD(+,) and thus limits its availability to different NAD(+) consuming enzymes (PARP, ART, and sirtuins) inside the cells. The present review discusses how the CD38-NAD(+) axis affects T cell activation and differentiation through interfering with their signaling and metabolic processes. We also describe the pivotal role of the CD38-NAD(+) axis in influencing the chromatin remodeling and rewiring T cell response. Overall, this review emphasizes the crucial contribution of the CD38(−)NAD(+) axis in altering T cell response in various pathophysiological conditions. |
format | Online Article Text |
id | pubmed-7408359 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74083592020-08-13 CD38: T Cell Immuno-Metabolic Modulator Kar, Anwesha Mehrotra, Shikhar Chatterjee, Shilpak Cells Review Activation and subsequent differentiation of T cells following antigenic stimulation are triggered by highly coordinated signaling events that lead to instilling cells with a discrete metabolic and transcriptional feature. Compelling studies indicate that intracellular nicotinamide adenine dinucleotide (NAD(+)) levels have profound influence on diverse signaling and metabolic pathways of T cells, and hence dictate their functional fate. CD38, a major mammalian NAD(+) glycohydrolase (NADase), expresses on T cells following activation and appears to be an essential modulator of intracellular NAD(+) levels. The enzymatic activity of CD38 in the process of generating the second messenger cADPR utilizes intracellular NAD(+,) and thus limits its availability to different NAD(+) consuming enzymes (PARP, ART, and sirtuins) inside the cells. The present review discusses how the CD38-NAD(+) axis affects T cell activation and differentiation through interfering with their signaling and metabolic processes. We also describe the pivotal role of the CD38-NAD(+) axis in influencing the chromatin remodeling and rewiring T cell response. Overall, this review emphasizes the crucial contribution of the CD38(−)NAD(+) axis in altering T cell response in various pathophysiological conditions. MDPI 2020-07-17 /pmc/articles/PMC7408359/ /pubmed/32709019 http://dx.doi.org/10.3390/cells9071716 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Kar, Anwesha Mehrotra, Shikhar Chatterjee, Shilpak CD38: T Cell Immuno-Metabolic Modulator |
title | CD38: T Cell Immuno-Metabolic Modulator |
title_full | CD38: T Cell Immuno-Metabolic Modulator |
title_fullStr | CD38: T Cell Immuno-Metabolic Modulator |
title_full_unstemmed | CD38: T Cell Immuno-Metabolic Modulator |
title_short | CD38: T Cell Immuno-Metabolic Modulator |
title_sort | cd38: t cell immuno-metabolic modulator |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408359/ https://www.ncbi.nlm.nih.gov/pubmed/32709019 http://dx.doi.org/10.3390/cells9071716 |
work_keys_str_mv | AT karanwesha cd38tcellimmunometabolicmodulator AT mehrotrashikhar cd38tcellimmunometabolicmodulator AT chatterjeeshilpak cd38tcellimmunometabolicmodulator |